<DOC>
	<DOCNO>NCT00871728</DOCNO>
	<brief_summary>The purpose study evaluate participant toenail onychomycosis ( fungal infection nail ) confirm positive potassium hydroxide ( KOH ) bacterial identification test administration itraconazole ( ICZ ) capsule , identify change Scoring Clinical Index Onychomycosis ( SCIO ) score determine relationship change SCIO score mycological cure rate clinical improvement .</brief_summary>
	<brief_title>Scoring Clinical Index For Onychomycosis Toenail Onychomycosis Treating With Itraconazole Capsules</brief_title>
	<detailed_description>This open-label ( people know identity intervention ) , multicenter ( one hospital medical school team work medical research study ) study ICZ participant onychomycosis . The present study consist 2 period : Screening period ( Week minus 2 ) Treatment period ( Week 49 ) . The ICZ administer 3 cycle ( Week 1 , Week 5 Week 9 ) cycle consist take 2 capsule 100 milligram ( mg ) , orally , twice daily , continuously 1 week . Total duration treatment 49 week . Efficacy primarily evaluate percentage participant show 10 percent high response SCIO Score . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>Onychomycosis participant whose etiologic agent identify potassium hydroxide ( KOH ) smear bacterial identification test Participants Scoring Clinical Index Onychomycosis ( SCIO ) great equal 9 Participants healthy general follow item : medical medication history , physical examination administration time , vital sign ( blood pressure pulse ) clinical laboratory test ( clinical test result [ liver function renal function ] within 2 time normal range ) Female participant childbearing age use acceptable contraceptive Participants understand feature clinical study sign informed consent form Participants psoriasis ( scaly skin rash ) Diabetic participant take antidiabetic drug Pregnant breast feed female participant Participants clinical evidence arterial insufficiency peripheral vascular disease medical history decrease ventricular function like congestive heart failure ( heterogeneous condition heart unable pump sufficient blood meet metabolic need body ) Participants apply topical antifungal agent ( nail lacquer ) target nail within 1 month study medication administration take oral antifungal agent within 3 month study medication administration</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Onychomycosis , Toe</keyword>
	<keyword>Itraconazole</keyword>
	<keyword>Sporanox</keyword>
</DOC>